دورية أكاديمية
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
| العنوان: | Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy |
|---|---|
| المؤلفون: | Passaro, A.Aff1, Mancuso, P., Gandini, S., Spitaleri, G., Labanca, V., Guerini-Rocco, E.Aff4, Aff5, Barberis, M., Catania, C., Del Signore, E., de Marinis, F., Bertolini, F. |
| المصدر: | Clinical and Translational Oncology. 22(4):621-621 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!